-
COMPARATIVE SEVERITY OF COVID-19, INFLUENZA, AND RSV HOSPITALIZATIONS IN FRANCE: A PROPENSITY SCORE ANALYSIS USING NATIONAL HOSPITAL DATA
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS OF SECOND-LINE TREATMENTS FOR ADVANCED AND METASTATIC GASTRIC CANCER IN THE IRISH HEALTHCARE-SETTING
Aug 11, 2026, 17:15 PM -
ECONOMIC IMPACT OF EMBOLIC AGENT CHOICE (LIQUID VS PARTICLES) IN MIDDLE MENINGEAL ARTERY EMBOLIZATION FOR CHRONIC SUBDURAL HEMATOMA : A NATIONAL HEALTHCARE SYSTEM PERSPECTIVE
Aug 11, 2026, 17:15 PM -
COMPARATIVE CLINICAL EFFICACY AND SAFETY OF EGFR-TKIS COMBINED WITH HERBAL MEDICINE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
Aug 11, 2026, 17:15 PM -
PUBLIC HEALTH IMPACT (PHI) OF RECOMBINANT ZOSTER VACCINE (RZV) FOR OLDER ADULTS AND IMMUNOCOMPROMISED PATIENTS IN BRAZIL
Aug 11, 2026, 17:15 PM -
EU5 PAYER READINESS FOR ANTI-AGEING THERAPEUTICS: AWARENESS, CONCERN, AND ANTICIPATED REIMBURSEMENT HURDLES
Aug 11, 2026, 17:15 PM -
CONTINUOUS EVIDENCE ORCHESTRATION: A HUMAN-GOVERNED, MCP-CONNECTED MULTI-AGENT GENAI PIPELINE FOR HEOR AND HTA
Aug 11, 2026, 17:15 PM -
CLINICAL HETEROGENEITY IN INDOLENT SYSTEMIC MASTOCYTOSIS: A GERMAN CLAIMS DATA ANALYSIS SUPPORTING THE NEED FOR MULTIDISCIPLINARY CARE
Aug 11, 2026, 17:15 PM -
MEDICAL COSTS AND HEALTHCARE RESOURCE UTILIZATION AMONG JAPANESE EPILEPSY PATIENTS WITH AND WITHOUT FREQUENT SEIZURE-RELATED EMERGENCIES: A COMPARATIVE DATABASE STUDY
Aug 11, 2026, 17:15 PM -
AUGMENTING THE ANALYST OR ASSISTING THE ASSISTANT: AI WORKFLOWS IN HTA STATISTICS
Aug 11, 2026, 17:15 PM -
COST-UTILITY ANALYSIS OF INCLISIRAN ADDED TO STANDARD OF CARE FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE: A PUBLIC PAYER PERSPECTIVE
Aug 11, 2026, 17:15 PM -
FROM BARRIERS TO ENABLERS: IDERHA POLICY RECOMMENDATIONS TO ENABLE HEALTH DATA SHARING FOR SECONDARY USE IN THE EUROPEAN HEALTH DATA SPACE
Aug 11, 2026, 17:15 PM -
EVALUATING THE IMPACT AND VALUE OF EARLIER SINGLE INHALER TRIPLE THERAPY (SITT) INITIATION IN COPD MANAGEMENT IN ARGENTINA, COLOMBIA AND VIETNAM: A COST-UTILITY MODELING STUDY
Aug 11, 2026, 17:15 PM -
ECONOMIC EVALUATION OF SOMATROPIN STERILE SOLUTION IN NEONATES AND YOUNG CHILDREN WITH GROWTH HORMONE DEFICIENCY-ASSOCIATED HYPOGLYCEMIA
Aug 11, 2026, 17:15 PM -
QUANTIFYING REAL-WORLD CORTICOSTEROID BURDEN IN MYASTHENIA GRAVIS TREATED WITH NOVEL BIOLOGIC THERAPIES
Aug 11, 2026, 17:15 PM -
CAN NATIONAL EARLY SCIENTIFIC ADVICE SUPPORT JCA READINESS IN THE ABSENCE OF JOINT SCIENTIFIC CONSULTATION?
Aug 11, 2026, 17:15 PM -
WHY EMA AND FDA USE THE WRONG MEASURE OF RARITY IN THEIR ORPHAN DRUG LEGISLATIONS
Aug 11, 2026, 17:15 PM -
EVALUATING AI-ASSISTED VERSUS MANUAL TARGETED LITERATURE REVIEWS: A CASE STUDY ON THE BURDEN OF ILLNESS IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
Aug 11, 2026, 17:15 PM -
WHAT MUST BE EXPLICIT? LESSONS FROM AI-ASSISTED IMPLEMENTATION OF A HEALTH ECONOMIC MODEL
Aug 11, 2026, 17:15 PM -
USES AND IMPACTS OF REAL-WORLD DATA (RWD) ON THE HAUTE AUTORITE DE SANTE
Aug 11, 2026, 17:15 PM
